The system is designed to help with treatment adherence by tracking medication use and reminding patients if a dose is missed. Airsupra is indicated for the as-needed treatment or prevention of ...
Kite’s Tecartus (brexucabtagene autoleucel), a customized, one-time therapy derived from a patient’s genetically modified T cells, has received accelerated approval for treating adults with relapsed ...
AstraZeneca’s fixed-dose triple-combination therapy BREZTRI Aerosphere® (budesonide/glycopyrrolate/formoterol fumarate or BGF 320/36/9.6μg) has been approved in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results